Full Press Release Details
WASHINGTON,Aug. 28, 2025/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:VNDA) today announced that the company will participate in the following upcoming investor conferences inSeptember 2025:
The Cantor Global Healthcare Conference 2025 inNew York CityonWednesday, September 3, 2025. A corporate presentation is scheduled for3:55 p.m. Eastern Time.
The 2025 Wells Fargo Healthcare Conference inBostononThursday, September 4, 2025. A corporate presentation is scheduled for4:30 p.m. Eastern Time.
The H.C. Wainwright Annual Global Investment Conference inNew York CityonTuesday, September 9, 2025. A corporate presentation is scheduled for8:30 a.m. Eastern Time.
The corporate presentations given at the Cantor, Wells Fargo and H.C. Wainwright conferences may be accessed live on Vanda's corporate website,www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visitwww.vandapharma.comand follow us on X @vandapharma.
Corporate Contact:Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc.202-734-3400[email protected]
Jim Golden/Jack Kelleher/Dan MooreCollected Strategies[email protected]